Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials.

Tracz MJ, Sideras K, Boloña ER, Haddad RM, Kennedy CC, Uraga MV, Caples SM, Erwin PJ, Montori VM.

J Clin Endocrinol Metab. 2006 Jun;91(6):2011-6. Epub 2006 May 23. Review.

PMID:
16720668
2.

Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials.

Haddad RM, Kennedy CC, Caples SM, Tracz MJ, Boloña ER, Sideras K, Uraga MV, Erwin PJ, Montori VM.

Mayo Clin Proc. 2007 Jan;82(1):29-39. Review.

PMID:
17285783
3.

Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis.

Isidori AM, Giannetta E, Greco EA, Gianfrilli D, Bonifacio V, Isidori A, Lenzi A, Fabbri A.

Clin Endocrinol (Oxf). 2005 Sep;63(3):280-93. Review.

PMID:
16117815
4.

Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials.

Boloña ER, Uraga MV, Haddad RM, Tracz MJ, Sideras K, Kennedy CC, Caples SM, Erwin PJ, Montori VM.

Mayo Clin Proc. 2007 Jan;82(1):20-8. Review.

PMID:
17285782
5.

Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.

Richy F, Schacht E, Bruyere O, Ethgen O, Gourlay M, Reginster JY.

Calcif Tissue Int. 2005 Mar;76(3):176-86. Epub 2005 Feb 7.

PMID:
15692726
6.

Strontium ranelate for preventing and treating postmenopausal osteoporosis.

O'Donnell S, Cranney A, Wells GA, Adachi JD, Reginster JY.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD005326. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD005326.

PMID:
16856092
7.

Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women.

Cranney A, Wells G, Willan A, Griffith L, Zytaruk N, Robinson V, Black D, Adachi J, Shea B, Tugwell P, Guyatt G; Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group.

Endocr Rev. 2002 Aug;23(4):508-16. Review.

PMID:
12202465
8.

Calcitonin for the treatment and prevention of corticosteroid-induced osteoporosis.

Cranney A, Welch V, Adachi JD, Homik J, Shea B, Suarez-Almazor ME, Tugwell P, Wells G.

Cochrane Database Syst Rev. 2000;(2):CD001983. Review.

PMID:
10796457
9.

Risedronate for the prevention and treatment of postmenopausal osteoporosis.

Cranney A, Waldegger L, Zytaruk N, Shea B, Weaver B, Papaioannou A, Robinson V, Wells G, Tugwell P, Adachi JD, Guyatt G.

Cochrane Database Syst Rev. 2003;(4):CD004523. Review. Update in: Cochrane Database Syst Rev. 2006;(1):CD004523.

PMID:
14584020
10.

WITHDRAWN: Risedronate for the prevention and treatment of postmenopausal osteoporosis.

Cranney A, Adachi JD, Guyatt G, Papaioannou A, Robinson VA, Shea BJ, Tugwell P, Waldegger LM, Weaver B, Wells G, Zytaruk N.

Cochrane Database Syst Rev. 2007 Jul 18;(1):CD004523. Review. Update in: Cochrane Database Syst Rev. 2008;(1):CD004523.

PMID:
17636764
11.

Interventions for preventing bone disease in kidney transplant recipients.

Palmer SC, McGregor DO, Strippoli GF.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005015. Review.

PMID:
17636784
12.

Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis.

Fernández-Balsells MM, Murad MH, Lane M, Lampropulos JF, Albuquerque F, Mullan RJ, Agrwal N, Elamin MB, Gallegos-Orozco JF, Wang AT, Erwin PJ, Bhasin S, Montori VM.

J Clin Endocrinol Metab. 2010 Jun;95(6):2560-75. doi: 10.1210/jc.2009-2575. Review.

PMID:
20525906
13.

Bisphosphonate therapy for children and adolescents with secondary osteoporosis.

Ward L, Tricco AC, Phuong P, Cranney A, Barrowman N, Gaboury I, Rauch F, Tugwell P, Moher D.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005324. Review.

PMID:
17943849
14.

Interventions for the treatment of decreased bone mineral density associated with HIV infection.

Lin D, Rieder MJ.

Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005645. Review.

PMID:
17443607
16.

Effects of vitamin D supplementation on bone density in healthy children: systematic review and meta-analysis.

Winzenberg T, Powell S, Shaw KA, Jones G.

BMJ. 2011 Jan 25;342:c7254. doi: 10.1136/bmj.c7254. Review.

17.

Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).

Gordon M, Naidoo K, Akobeng AK, Thomas AG.

Evid Based Child Health. 2013 Jan;8(1):57-109. doi: 10.1002/ebch.1893. Review.

PMID:
23878124
18.

Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis.

Reid IR, Bolland MJ, Grey A.

Lancet. 2014 Jan 11;383(9912):146-55. doi: 10.1016/S0140-6736(13)61647-5. Epub 2013 Oct 11. Review.

PMID:
24119980
19.

Effects of testosterone on sexual function in men: results of a meta-analysis.

Isidori AM, Giannetta E, Gianfrilli D, Greco EA, Bonifacio V, Aversa A, Isidori A, Fabbri A, Lenzi A.

Clin Endocrinol (Oxf). 2005 Oct;63(4):381-94. Review.

PMID:
16181230
20.

Alendronate for the treatment of osteoporosis in men.

Orwoll E, Ettinger M, Weiss S, Miller P, Kendler D, Graham J, Adami S, Weber K, Lorenc R, Pietschmann P, Vandormael K, Lombardi A.

N Engl J Med. 2000 Aug 31;343(9):604-10.

Supplemental Content

Support Center